Published on in Vol 6 , No 8 (2017) :August

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain

Ian Gilron 1 , MSc, MD ;   Dongsheng Tu 2 , PhD ;   Ronald Holden 2 , PhD ;   Tanveer Towheed 2 , MD ;   Elizabeth Vandenkerkhof 2 , DrPH ;   Roumen Milev 2 , MD, PhD

1 Queen's University , Department of Anesthesiology and Perioperative Medicine , Queen's University , Kingston , ON , CA

2 Division of Cancer Care and Epidemiology , Queen's Cancer Research Institute , Kingston , ON , CA

Corresponding Author:

  • Ian Gilron, MSc, MD
  • Queen's University
  • Department of Anesthesiology and Perioperative Medicine
  • Queen's University
  • Kingston General Hospital
  • 76 Stuart Street, Victory 2 Pavillion
  • Kingston, ON
  • CA
  • Phone: 1 613 549 6666 ext 3963
  • Email: gilroni@queensu.ca